📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Repligen

1.1 - Company Overview

Repligen Logo

Repligen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.

Products and services

  • XCell® ATF Systems: Stainless steel-format upstream bioprocessing system achieving high cell retention, also available in single-use format for manufacture of biological drugs
  • KrosFlo® TFF Systems: Single-use-compatible tangential flow filtration systems performing ultrafiltration, diafiltration, and microfiltration to support manufacture of biological drugs
  • ProConnex® Flow Paths: Single-use plug-and-play flow paths engineered for optimal performance in TFF and chromatography processes for manufacture of biological drugs

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Repligen

Femtogenix Logo

Femtogenix

HQ: United Kingdom Website
  • Description: Provider of next-generation DNA-interactive payload molecules for antibody-drug conjugates, discovered and developed via a platform that combines proprietary computational chemistry techniques with founder know-how from over 50 years of DNA-targeted drug experience. Founded in 2015.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Femtogenix company profile →
Aran Biomedical Logo

Aran Biomedical

HQ: Ireland Website
  • Description: Provider of design, development, and manufacturing of biomaterial-based medical implants, specializing in medical textiles, implant coatings, biomaterial frame encapsulation, and resorbable implantable solutions. Services span concept development, prototyping, and volume manufacturing, with knitting, braiding, weaving for implantable polymers, plus dip and spray coating using resorbable and non-resorbable materials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aran Biomedical company profile →
BioGene Logo

BioGene

HQ: United Kingdom Website
  • Description: Provider of a solution-based portfolio of products, services, and support covering key application areas of molecular biology, dedicated to developing and implementing molecular and engineering technologies to improve access to diagnostic testing and enhance global health outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioGene company profile →
BioServ Logo

BioServ

HQ: United Kingdom Website
  • Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioServ company profile →
Signal Pharmaceuticals Logo

Signal Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions, headquartered in San Diego, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Signal Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Repligen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Repligen

2.2 - Growth funds investing in similar companies to Repligen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Repligen

4.2 - Public trading comparable groups for Repligen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Repligen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Repligen

What does Repligen do?

Repligen is a provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.

Who are Repligen's competitors?

Repligen's competitors and similar companies include Femtogenix, Aran Biomedical, BioGene, BioServ, and Signal Pharmaceuticals.

Where is Repligen headquartered?

Repligen is headquartered in United States.

How many employees does Repligen have?

Repligen has 1,000 employees 🔒.

When was Repligen founded?

Repligen was founded in 2010 🔒.

What sector and industry vertical is Repligen in?

Repligen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Repligen

Who are the top strategic acquirers in Repligen's sector and industry

Top strategic M&A buyers and acquirers in Repligen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Repligen?

Top strategic M&A buyers groups and sectors for Repligen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Repligen's sector and industry vertical

Which are the top PE firms investing in Repligen's sector and industry vertical?

Top PE firms investing in Repligen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Repligen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Repligen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Repligen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Repligen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Repligen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Repligen?

The key public trading comparables and valuation benchmarks for Repligen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Repligen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Repligen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Repligen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Repligen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Repligen's' sector and industry vertical?

Access recent funding rounds and capital raises in Repligen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Repligen